Back to Insights

UW Carbone Cancer Center - Support of the Flow Cytometry Laboratory

April 7th, 2021

Resonant Capital Advisors built our business to represent our families, friends and the overall communities where we live. As part of this effort, we support a number of institutions and organizations that reflect the values of our employees and clients. These community posts reflect some of our commitment to these beliefs. We welcome your feedback and ideas on these initiatives.

Carbone Cancer Center

The Resonant Capital Advisors team has proudly supported the University of Wisconsin Carbone Cancer Center for a number of years in its work in research and patient care, along with innovations in treating, preventing and defeating cancer.

The center, which is the only comprehensive cancer center in Wisconsin and has received the highest ranking given by the National Cancer Institute (NCI), provides a number of opportunities for people to support the organization in this challenging mission.

An effort currently underway that Resonant Capital has proudly sponsored is the support of the Flow Cytometry Laboratory on campus. The funds will be used to help advance the software that is used in the lab, which is critical to the research done at Carbone Center and also across the UW-Madison campus.

Flow Cytometry is a cell-analysis technique used to detect and measure physical and chemical characteristics of a population of cells or particles.

You can learn more about the specifics of this effort at the following link, which also includes a video from Dr. Howard Bailey, the director of the UW Carbone Cancer Center. Resonant Capital's CEO and Chief Investment Strategist Walter Dewey is a longtime member of the Carbone Center's advisory board.